Crohn'
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients adapted for small bowel capsule endoscopy 2. Patients confirmed diagnosis of Crohn's disease 3. Patients who are confirmed patency by patency capsule 4. Patients with Ileal, Ileocollic, or aphthous-type Crohn's disease 5. Patients without history of abdominal surgery
Exclusion criteria
Exclusion criteria: 1. Patients with malignant tumor 2. Patients with acute abdomen 3. Patients with serious acute inflammation 4. Patients with pregnant woman 5. Patients who cannot be confirmed GI patency under patency capsule 6. Patient's general health is extremely poor, Patients who has risk for performing endoscopy such as ileus, perforation, pancreatitis, respiratory disorder, cardiovascular disorder, acquired hemophilia, stenosis, large ulcer, or tumor 7. Patients with active lesions in colon 8. Patients with stoma 9. Patients with history of abdominal surgery 10. Patients with habitual NSAIDs consumption 11. Colonic Crohn's disease 12. Patients used to participate in this trial 13. Also, patients who are judged not suitable for this trial by the doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlation between Lewis score of small bowel capsule endoscopy and fecal calprotectin | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Correlation between fecal calprotectin and Alb, CRP, or ESR 2. Correlation between fecal calprotectin and HBI 3. Correlation between fecal calprotectin and CECDAI 4. Cleansing level of small bowel capsule endoscopy | — |
Countries
Japan
Contacts
Fukuoka University Chikushi Hospital Department of Gastroenterology